Biologics Contract Manufacturing Market Size and Competitive Landscape
According to Shivani Zoting, who specializes in biopharmaceuticals, healthcare research, and life sciences market analysis, with 5+ years of experience in market research and industry analysis. Her research reveals that the biologics contract manufacturing market is projected to grow from USD 23.99 billion in 2026 to USD 55.65 billion by 2035, driven by rising biologics demand and outsourcing trends. The analysis highlights key segments including monoclonal antibodies, cell & gene therapies, mammalian cell systems, upstream processing, and pharmaceutical end users, while examining regional growth across North America and Asia Pacific. The study also evaluates competitive dynamics among leading companies such as Thermo Fisher Scientific, AGC Biologics, Catalent, and Boehringer Ingelheim.
Last Updated : 06 August 2026
Category: Healthcare Services
Insight Code: 6868
Format: PDF / PPT / Excel